Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Novosom purchases option from Isis
Novosom plans to target CD40 for indications such as Crohn's disease, transplant, rheumatoid arthritis, cancer and multiple sclerosis. If acquired, the license from Isis would include rights to
Novosom plans to target CD40 for indications such as Crohn's disease, transplant, rheumatoid arthritis, cancer and multiple sclerosis. If acquired, the license from Isis would include rights to
<p>The new facility, Abbott Biotechnology Limited (ABL), received FDA approval in February to commercially produce Humira for the US market. The new plant is Abbott's single-largest capital investment
<p>The notice referred to the patents that cover the method of use and formulation of Endo's lidocaine-containing topical patch products, Lidoderm and Synera. <br /><br />If approved, Endo
The agreement includes Transgene’s lead therapeutic vaccine candidate TG 4001, currently in clinical development to treat neoplasia, a precancerous cervical abnormality which can lead to cervical cancer. Under
Davanat is co-administered with 5-Fluorouracil (5-FU) to treat cancer patients. 5-FU is an FDA-approved chemotherapy drug that is used to treat various types of cancers, including colorectal, breast
Johnson & Johnson said the voluntary recall is a precaution based on two reports of glass fragments found in bottles of the liquid formulation. The voluntary recall is
This extension provides Renovis with additional research funding through to June 2008 and reflects the goal of Pfizer and Renovis to advance multiple, small molecule VR1 antagonists toward
This phase II study is designed to evaluate the safety and efficacy of the eye drop, ATG3, in patients with age-related macular degeneration (AMD). All patients will be
The Thai government has said it is considering the offer by Abbott to supply the medicine to its country and other low income countries. The offer comes after
The objective of this study was to evaluate the compound's preliminary safety and tolerability by treating six separate groups of healthy volunteers. In addition to safety and tolerability,